Skip to main content

Find Clinical Trials

Home
Conditions
Intestinal Diseases

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,808 public trials 2,261 recruiting studies

Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Terminated

A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6

NCT06091930

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +26 more
Locations: National Cancer Center Hospital East Chiba, Kashiwa, Japan

National Cancer Center Hospital Tokyo, Chuo-ku, Japan

Japanese Foundation for Cancer Research Tokyo, Koto-ku, Japan

View Trial Details

Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions: Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations: Arizona Oncology Associates Tucson, Arizona, United States

Rocky Mountain Cancer Centers Aurora, Colorado, United States

St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States

Ochsner Cancer Institute New Orleans, Louisiana, United States

View all 17 locations

View Trial Details

Terminated

Study of ExoFlo for the Treatment of Perianal Fistulas

NCT05836883

Conditions: Crohn Disease, Crohn's Disease, Digestive System Diseases, +5 more
Locations: Direct Biologics Investigational Site Los Angeles, California, United States

View Trial Details

Terminated

Nicotinamide Riboside in Ulcerative Colitis

NCT05561738

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: UPMC Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Suspended

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

NCT06102902

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations: UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

View all 15 locations

View Trial Details

Withdrawn

Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Signatures

NCT05579483

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Wageningen University Wageningen, Gelderland, Netherlands

View Trial Details

Withdrawn

CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

NCT07090174

Conditions: Acquired Immunodeficiency Syndrome, Anal Cancer, Anus Diseases, +40 more
Locations: Weill Cornell Medical College New York, United States

Montefiore Medical Center/Albert Einstein College of Medicine The Bronx, New York, United States

University of Puerto Rico San Juan, Puerto Rico

View Trial Details

Withdrawn

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

NCT06221423

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +11 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details